Skip to content
Lower risk Drug recall · FDA · Published April 15, 2022

Dr. Reddy's Lansoprazole Tablets Recall: Failed Dissolution Risk

Dr. Reddy's recalls 30mg Lansoprazole tablets due to failed dissolution specifications. This may affect medication effectiveness. Check your product details and contact the manufacturer for guidance.

🇺🇸 FDA recall #D-0853-2022DrugDr. Reddy's ›
Take action

Contact the company

Recalling firmDr. Reddy's Laboratories, Inc.107 College Rd E · Princeton, NJ 08540-6623
✎ GovInfoNow plain-language explainer

Dr. Reddy's is recalling 30mg Lansoprazole Delayed-Release Orally Disintegrating Tablets because they may not dissolve properly. This could lead to inconsistent medication delivery, but the recall does not mention serious injury risks. Read more at govinfonow.com/recall/34833-dr-reddy-s-lansoprazole-tablets-recall-failed-dissolution-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/34833-dr-reddy-s-lansoprazole-tablets-recall-failed-dissolution-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0853-2022

Cite this page

“Dr. Reddy's Lansoprazole Tablets Recall: Failed Dissolution Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34833-dr-reddy-s-lansoprazole-tablets-recall-failed-dissolution-risk. Based on FDA recall #D-0853-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0853-2022%22&limit=1).

The FDA announced on April 15, 2022, that Dr. Reddy's Laboratories, Inc. voluntarily recalled Lansoprazole Delayed-Release Orally Disintegrating Tablets due to failed dissolution specifications. The recall affects 252 blister packs distributed in Ohio.

How to tell if you have it

  • Brand: Dr. Reddy's
  • Product: Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg
  • Packaging: 10 Packs of 10 Tablets each, 100 Tablets per blister pack
  • NDC: 43598-561-78
  • Lot #: T2000645
  • Expiration Date: 07/2022
  • Quantity: 252 Blister Packs
  • Distribution: Ohio

The hazard

The recalled Lansoprazole tablets failed to meet dissolution specifications. The FDA classified this recall as Class II.

Context

GovInfoNow's records show Dr. Reddy's Laboratories, Inc. has had 85 other recalls on record since April 9, 2012. Other recent recalls of similar products include Dr. Reddy's Varenicline Tablets Recall (Nov. 11, 2025), Dr. Reddy's Succinylcholine Chloride Injection Recall (Sept. 26, 2025), and Dr. Reddy's Omeprazole Capsules Recall (June 30, 2025). Other recent recalls of similar products include AvKARE Rosuvastatin Tablets 10mg Recall (Dec. 31, 2025), Lannett Niacin Extended-release Tablets Recall (May 27, 2026), and Teva Metoprolol Succinate Tablets Recall (Jan. 29, 2026).

How to tell if you have this one

Look for the product name 'Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg' with 10 packs of 10 tablets per blister. The lot number T2000645 and expiration date 07/2022 are also key identifiers.

  • Brand
    Dr. Reddy's
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product name, lot number T2000645, and expiration date 07/2022 to confirm if it's recalled.

Where it went and when

Where it was distributed

Distributed in Ohio.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “OH” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Ohio.

Recall timeline

FDA terminated this recall 19 months after the firm started it.

1. Firm started the recall: Apr 15, 202212. FDA classified it Class II: May 5, 202223. Published in FDA’s Enforcement Report: May 11, 202234. FDA terminated the recall: Nov 7, 2023420222023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Dr. Reddy's recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0853-2022 (April 15, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0853-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA